Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer

Gynecologic Oncology

Volumn 129, Issue 1, 2013, Pages 18-21

  Townamchai, Kanokpis ^a   Berkowitz, Ross ^a   Bhagwat, Mandar ^a   Damato, Antonio L ^a   Friesen, Scott ^a   Lee, Larissa J ^a   Matulonis, Ursula ^b   O'Farrell, Desmond ^a   Viswanathan, Akila N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

High dose rate brachytherapy; Uterine papillary serous cancer; Vaginal brachytherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; PACLITAXEL;

ABDOMINAL WALL; ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; TREATMENT DURATION; VAGINA; VAGINAL BRACHYTHERAPY;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CYSTADENOCARCINOMA, PAPILLARY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE NEOPLASMS; VAGINA;

EID: 84875442602     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.12.026     Document Type: Article

References (28)

1. C.A. Hamilton, M.K. Cheung, K. Osann, L. Chen, N.N. Teng, and T.A. Longacre Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers Br J Cancer 94 5 Mar 13 2006 642 646
2. W.T. Creasman, M.F. Kohler, F. Odicino, P. Maisonneuve, and P. Boyle Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium Gynecol Oncol 95 3 Dec 2004 593 596
3. D.M. Boruta II, P.A. Gehrig, A.N. Fader, and A.B. Olawaiye Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 115 1 Oct 2009 142 153
4. A.B. Olawaiye, and D.M. Boruta II Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 113 2 May 2009 277 283
5. A.N. Fader, R.D. Drake, D.M. O'Malley, H.E. Gibbons, W.K. Huh, and L.J. Havrilesky Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma Cancer 115 10 May 15 2009 2119 2127
6. A.N. Fader, C. Nagel, A.E. Axtell, K.M. Zanotti, J.L. Kelley, and K.N. Moore Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes Gynecol Oncol 112 3 Mar 2009 558 562
7. A.N. Viswanathan, E.A. Macklin, R. Berkowitz, and U. Matulonis The importance of chemotherapy and radiation in uterine papillary serous carcinoma Gynecol Oncol 123 3 Dec 2011 542 547
8. A.P. Kiess, S. Damast, V. Makker, M.A. Kollmeier, G.H. Gardner, and C. Aghajanian Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer Gynecol Oncol 127 Jul 2012 321 325
9. M.G. Kelly, D.M. O'Malley, P. Hui, J. McAlpine, H. Yu, and T.J. Rutherford Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy Gynecol Oncol 98 3 Sep 2005 353 359
10. L. Gallagher, M. Hughes, and N. Mcmillian National Comprehensive Cancer Network clinical practice guideline in oncology, uterine neoplasm vol. 3 2012
11. E.C. Batchelor, J.M. Watkins, W.T. Creasman, M.F. Kohler, D. Sinha, and J.M. Jenrette The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma Eur J Obstet Gynecol Reprod Biol 141 2 Dec 2008 163 168
12. N. Mehta, S.D. Yamada, J. Rotmensch, and A.J. Mundt Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy Int J Radiat Oncol Biol Phys 57 4 Nov 15 2003 1004 1009
13. T. Hogberg, M. Signorelli, C.F. de Oliveira, R. Fossati, A.A. Lissoni, and B. Sorbe Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - results from two randomised studies Eur J Cancer 46 13 Sep 2010 2422 2431
14. W.K. Huh, M. Powell, C.A. Leath III, J.M. Straughn, D.E. Cohn, and M.A. Gold Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy Gynecol Oncol 91 3 Dec 2003 470 475
15. R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 9717 Mar 6 2010 816 823
16. R.R. Barakat, G. Lev, A.J. Hummer, Y. Sonoda, D.S. Chi, and K.M. Alektiar Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches Gynecol Oncol 105 1 Apr 2007 150 156
17. K.M. Alektiar, V. Makker, N.R. Abu-Rustum, R.A. Soslow, D.S. Chi, and R.R. Barakat Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer Gynecol Oncol 112 1 Jan 2009 142 145
18. B.M. Barney, I.A. Petersen, A. Mariani, S.C. Dowdy, J.N. Bakkum-Gamez, and M.G. Haddock The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer Int J Radiat Oncol Biol Phys 85 Apr 2013 109 115
19. W. Small Jr., B. Erickson, and F. Kwakwa American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy Int J Radiat Oncol Biol Phys 63 5 Dec 1 2005 1502 1507
20. W. Small Jr., S. Beriwal, D.J. Demanes, K.E. Dusenbery, P. Eifel, and B. Erickson American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy Brachytherapy 11 1 Jan-Feb 2012 58 67
21. K. Townamchai, L. Lee, and A.N. Viswanathan A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer Gynecol Oncol 127 Jul 2012 351 355
22. W. Creasman Revised FIGO staging for carcinoma of the endometrium Int J Gynaecol Obstet 105 2 May 2009 109
23. B. Sorbe, A. Straumits, and L. Karlsson Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels Int J Radiat Oncol Biol Phys 62 5 Aug 1 2005 1385 1389
24. A. Fayed, D.G. Mutch, J.S. Rader, R.K. Gibb, M.A. Powell, and J.D. Wright Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma Int J Radiat Oncol Biol Phys 67 2 Feb 1 2007 480 484
25. B. DuBeshter, K. Estler, K. Altobelli, S. McDonald, C. Glantz, and C. Angel High-dose rate brachytherapy for stage I/II papillary serous or clear cell endometrial cancer Gynecol Oncol 94 2 Aug 2004 383 386
26. K.M. Alektiar, A. McKee, O. Lin, E. Venkatraman, M.J. Zelefsky, and B. McKee Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO grade 3 cancer? Int J Radiat Oncol Biol Phys 54 1 Sep 1 2002 79 85
27. B.C. Turner, J.P. Knisely, B.M. Kacinski, B.G. Haffty, A.A. Gumbs, and K.B. Roberts Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy Int J Radiat Oncol Biol Phys 40 1 Jan 1 1998 77 84
28. K.T. Murphy, J. Rotmensch, S.D. Yamada, and A.J. Mundt Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy Int J Radiat Oncol Biol Phys 55 5 Apr 1 2003 1272 1276